|Type||Activity||URL||Description||Deadline||I am interested|
|NIAID Investigator Initiated Program Project Applications||P01||This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs may address scientific areas relevant to the NIAID mission including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of normal immune function system development and function; and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases. Each P01 application submitted to this FOA must include at least two related research projects that share a common central theme, focus, and/or overall objective.||September 8, 2019|
|NHLBI Program Project Applications||P01||This Funding Opportunity Announcement (FOA), issued by the National Heart, Lung, and Blood Institute (NHLBI) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs may address scientific areas relevant to the NHLBI mission including the biology and diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders. Each application submitted in response to this FOA must include at least three related research projects that share a common central theme, focus, and/or overall objective.||September 26, 2017|
|NIDA Program Project Grant Applications||P01||This Funding Opportunity Announcement (FOA) announces the availability of support for collaborative research by multi-disciplinary teams which is of high priority to NIDA and leads to synergistic outcomes based on the synthesis of multiple research approaches. The NIDA Program Projects funding opportunity will support research in which the funding of three or more highly meritorious projects as a group enriches both the component projects and the overall program to offer significant scientific advantages over supporting the same projects as individual research grants (i.e., synergy). For the duration of the award, each Program must consist of a minimum of three research projects focused on issues critical to advance the mission and goals of NIDA.||September 8, 2019|
|NCI Program Projects||P01||Summary: With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated program project (P01) grants. Proposed program projects may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each Program Project application must consist of at least three projects. The projects must share a common central theme, focus, and/or overall objective.||January 8, 2020|
|NIA Program Projects||P01||The National Institute on Aging invites the submission of investigator-initiated program project (P01) applications. The applications should address scientific areas relevant to the NIA mission. Each application submitted to this FOA must include at least three related research projects that share a common central theme, focus, and/overall objective and an administrative core to lead the project.||May 25, 2017; January 25, 2018; May 25, 2018; January 25, 2019; May 28, 2019|
|NIDDK Program Projects||P01||Summary: This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated program project applications. The proposed programs should address scientific areas relevant to the NIDDK mission including diabetes, selected endocrine and metabolic diseases, obesity, digestive diseases and nutrition, and kidney, urologic and hematologic diseases, as well as new approaches to prevent, treat and cure these diseases, including clinical research.||May 8, 2019|
|NINDS Program Projects||P01||Summary: This funding opportunity announcement (FOA) is issued to enable submission of program project grant applications that propose to conduct innovative, interactive, high impact research. Applications should address significant scientific questions that are important for the mission of NINDS, via a synergistic collaboration between outstanding scientists who might not otherwise collaborate. The program project grant is designed to support research in which the funding of several interdependent highly meritorious projects as a group offers significant scientific advantages over support of these same projects as individual research grants.||May 8, 2017|
|Support of NIGMS Program Project Applications||P01||This funding opportunity announcement (FOA) issued by the National Institute of General Medical Sciences encourages innovative, interactive Program Project grant applications from institutions/organizations that propose to conduct research which aims to solve a significant biological problem, important for the mission of NIGMS, through a collaborative approach involving outstanding scientists. The Program Project grant is designed to support research in which the funding of several interdependent projects as a group offers significant scientific advantages over support of these same projects as individual regular research grants.||May 25, 2017; January 25, 2018; May 25, 2018|
|Center of Excellence for Research on Complementary and Integrative Health||P01||This funding opportunity announcement (FOA) encourages the submission of applications that requires multi-project, synergistic collaboration between outstanding scientists that blends multiple research approaches by multi-disciplinary research teams. This Center of Excellence for Research on Complementary and Integrative Health (CERCIH) program is designed to support three or more highly meritorious projects that can offer significant scientific advantages and "synergy" that could not be achieved by supporting the same projects as individual research grants. Each CERCIH must be focused on questions of high relevance to the mission of NCCIH.||January 8, 2020|
|HIV Vaccine Research and Design (HIVRAD) Program||P01||Summary: The HIV Vaccine Research and Design (HIVRAD) program is designed to fund projects that further address hypotheses crucial to the design of an efficacious HIV/AIDS prophylactic vaccine. Applications for five years of support should include plans that have advanced past the exploratory stage and include preliminary data. Less fully developed applications can request less than 5 years of support to establish feasibility. Applications aimed at developing or optimizing a specific vaccine platform should lay out a research pathway with clear decision points. Extensive modeling of vaccine concepts in non-human primates may be included.||July 14, 2017|
|Core Centers for Clinical Research (CCCR)||P30||The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Core Centers for Clinical Research (CCCR) (P30) within its mission. The CCCRs will provide avenues to advance the methodological sciences that support clinical research within and across the NIAMS' portfolio of diseases.
The overall goals of the CCCR are to advance prevention, diagnosis and treatment of musculoskeletal, rheumatologic, and skin diseases by developing and fostering the implementation of novel methods, metrics, and outcome measures that address critical existing and emerging clinical research needs.
|January 17, 2019|
|NIDA Core "Center of Excellence" Grant Program||P30||NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are encouraged. A P30 should integrate and promote research in existing funded projects, to achieve new and creative directions. It is expected that individual core activities reflect a relationship to the integrating theme of the Center and the Center is expected to support the education, training, and mentoring of new investigators, and share findings, data and their resources.||January 8, 2020|
|Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers||P30||This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers. CCSGs support two types of cancer centers:
1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; and prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these scientific areas; and
2) Cancer Centers, which are primarily focused on basic laboratory; clinical; and prevention, cancer control, and population-based research; or some combination of these areas.
The purpose of both types of NCI-designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious programs in laboratory, clinical, and population research into a single transdisciplinary research enterprise across all institutional boundaries. Cancer Centers supported through this FOA are expected: to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of shared resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community.
|January 8, 2020|
|Diabetes Research Centers||P30||Summary: This Funding Opportunity Announcement (FOA) invites applications for Diabetes Research Centers that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. Diabetes Research Centers support three primary research-related activities: Research Core services, a Pilot and Feasibility (P and F) program, and an Enrichment program. All activities pursued by Diabetes Research Centers are designed to enhance the efficiency, productivity, effectiveness and multidisciplinary nature of research in Diabetes Research Center topic areas. The NIDDK Diabetes Research Centers program in 2016 consists of 16 Centers each located at outstanding research institutions with documented programs of excellence in diabetes-related research.||February 28, 2017|
|Silvio O. Conte Digestive Diseases Research Core Centers||P30||This Funding Opportunity Announcement (FOA) invites applications for Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs). The DDRCCs are part of an integrated program of digestive and liver diseases research support provided by the NIDDK. The purpose of this Centers program is to bring together basic and clinical investigators as a means to enhance communication, collaboration, and effectiveness of ongoing research related to digestive and/or liver diseases. DDRCCs are based on the core concept, whereby shared resources aimed at fostering productivity, synergy, and new research ideas among the funded investigators are supported in a cost-effective manner. Each proposed DDRCC must be organized around a central theme that reflects the focus of the digestive or liver diseases research of the Center members. The central theme must be within the primary mission of NIDDK, and not thematic areas for which other NIH Institutes or Centers are considered the primary source of NIH funding.||June 1, 2018|
|AIDS Research Center on Mental Health & HIV/AIDS||P30||Summary: The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support an HIV/AIDS Research Center (ARC). The ARC is intended to provide infrastructural support that facilitates the development of high impact science in HIV/AIDS and mental health that is relevant to the NIMH mission. This FOA intends to support innovative, interdisciplinary research in several areas, including basic, neurological (i.e., neuro-AIDS), behavioral and social, integrated biobehavioral, applied, clinical, translational, and implementation science.||September 14, 2017|
|Developmental AIDS Research Center on Mental Health and HIV/AIDS||P30||Summary: The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support Developmental AIDS Research Centers (D-ARC). The D-ARC is intended to provide infrastructural support that facilitates the development of high impact science in HIV/AIDS and mental health that is relevant to the NIMH mission. This FOA intends to support innovative, interdisciplinary research in several areas, including basic, neurological (i.e., neuro-AIDS), behavioral and social, integrated biobehavioral, applied, clinical, translational, and implementation science.||September 14, 2017|
|NIDCD Clinical Research Center Grant||P50||Summary: The National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications for Clinical Research Center Grants designed to advance the diagnosis, prevention, treatment, and amelioration of human communication disorders. For this announcement, Clinical Research is defined as research involving individuals with communication disorders or data/tissues from individuals with a communication disorder. Examples of such research include but are not limited to, studies of the prevention, pathogenesis, pathophysiology, diagnosis, treatment, management or epidemiology of a disease or disorder of hearing, balance, smell, taste, voice, speech, or language.||June 1, 2017; October 2, 2017; February 1, 2018; June 1, 2018; October 1, 2018; February 1, 2019; June 3, 2019|
|Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers||P50||This Funding Opportunity Announcement (FOA) invites applications for centers to support transdisciplinary teams of clinical and mental health services researchers, behavioral scientists, social scientists, health information and communications technologists, health systems engineers, decision scientists, and mental health stakeholders (e.g., service users, family members, clinicians, payers) to engage in high-impact studies that will significantly advance clinical practice and generate knowledge that will fuel transformation of mental health care in the United States. Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers will support the rapid development, testing, and refinement of novel and integrative approaches for:
(1) Optimizing the effectiveness of therapeutic or preventive interventions for mental disorders within well-defined target populations;
(2) Organizing and delivering optimized mental health services within real world treatment settings; and
(3) Continuously improving the quality, impact, and durability of optimized interventions and service delivery within diverse care systems.
The ALACRITY Centers program is intended to support research that demonstrates an extraordinary level of synergy across disciplines and has a high potential for increasing the public health impact of existing and emerging mental health interventions and service delivery strategies. The Centers are intended for transdisciplinary projects that could not be achieved using standard research project grant mechanisms. The ALACRITY Centers program is also expected to provide opportunities for graduate students, postdoctoral researchers, and new investigators to participate in transdisciplinary, T2 translational mental health research.
|May 17, 2017: May 17, 2018|
|NIDA Research Center of Excellence Grant||P50||Summary: This Funding Opportunity Announcement (FOA) is to provide support for research Centers that:
(1) conduct drug abuse and addiction research in any area of NIDAs mission,
(2) have outstanding innovative science,
(3) are multidisciplinary, thematically integrated, synergistic, and
(4) serve as national resource(s) to provide educational and outreach activities to drug abuse research communities, educational organizations, the general public, and policy makers in the NIDA research fields.
It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are required. The P50 Center of Excellence is expected to foster the career development and mentoring of new investigators who would be given meaningful roles to play in the Center projects. A goal of this program is to create NIDA Centers that are national community resources for furthering drug abuse research by sharing their findings, their data, and their resources as appropriate for researchers to use and build upon and to advance research in this field.
|September 25, 2017; September 25, 2018 (AIDS dates January 7)|
|Research Centers in Minority Institutions||U54||The purpose of the Research Centers in Minority Institutions (RCMI) Program is to expand the national capacity for research in the health sciences by providing cooperative agreement support to institutions that offer doctorate degrees in the health professions or in a health-related science and have a historical and current commitment to educating underrepresented students, and for institutions that deliver health care services, providing clinical services to medically underserved communities.
The primary goals of the RCMI specialized centers are to:
(1) enhance institutional research capacity within the areas of basic biomedical, behavioral, and/or clinical research;
(2) enable all levels of investigators to become more successful in obtaining competitive extramural support, especially from NIH, particularly on diseases that disproportionately impact minority and other health disparity populations;
(3) foster environments conducive to career enhancement with a special emphasis on development of new and early career investigators;
(4) enhance the quality of all scientific inquiry and promote research on minority health and health disparities; and
(5) establish sustainable relationships with community-based organizations that will partner with the RCMI Institution.
|March 7, 2017|
|Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence||U54||Summary: This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54s). The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, and pesticides. The scope of the research includes target and candidate identification and characterization, through candidate optimization and demonstration of in vivo efficacy, consistent with the product's intended use in humans For applicants submitting U54 renewal applications, research under this FOA should culminate in an optimized lead compound ready for advanced development. The Centers will contain at least three research projects supported by administrative and up to three optional scientific cores, and a research education core. Each research project must include milestones that create discrete go or no-go decision points in a progressive translational study plan.||September 12, 2017|
|Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials||Collaborative UG3/UH3||Summary: This Funding Opportunity Announcement (FOA) supports applications to develop and implement a Clinical Coordinating Center for investigator-initiated multi-site clinical trials (Phase II and beyond). Trials for which this FOA applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015).||June 13, 2017; October 11, 2017; February 13, 2018; June 13, 2018; October 11, 2018; February 13, 2019; June 13, 2019|
|Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials||Collaborative U24||Summary: This Funding Opportunity Announcement (FOA) supports applications for a collaborating Data Coordinating Center (DCC) for investigator-initiated multi-site clinical trials (Phase II and beyond). Trials for which this FOA applies must be relevant to the research mission of the NHLBI and meet the definition of an NIH clinical trial (see NOT-OD-15-015).||June 13, 2017; October 11, 2017; February 13, 2018; June 13, 2018; October 11, 2018; February 13, 2019; June 13, 2019|
|Type||URL||Description||Deadline||I am interested|
|Centers for Chemical innovation (CCI)||The Centers for Chemical Innovation (CCI) Program supports research centers focused on major, long-term fundamental chemical research challenges. CCIs that address these challenges will produce transformative research, lead to innovation, and attract broad scientific and public interest. CCIs are agile structures that can respond rapidly to emerging opportunities and make full use of data infrastructure and other approaches to enhance collaborations. CCIs may partner with researchers from industry, government laboratories and international organizations. CCIs integrate research, innovation, education, broadening participation, and informal science communication.||TBD|
|Engineering Research Centers (ERC)||The goal of the ERC Program is to integrate engineering research and education with technological innovation to transform national prosperity, health, and security. ERCs create an innovative, inclusive culture in engineering to cultivate new ideas and pursue engineering discovery that achieves a significant science, technology, and societal outcome within the 10-year timeframe of NSF support. For information on individual ERCs and their achievements, go to: ERC-assoc.org.
Those who submit proposals in response to this solicitation will need to address the following questions:
1. What is the compelling new idea and how does it relate to national needs?
2. Why is a center necessary to tackle the idea? 3. How will the ERC's infrastructure integrate and implement research, workforce development and innovation ecosystem development efforts to achieve its vision?
|Preliminary expected September 2017|
|Innovation Corps - National Innovation Network Sites Program (I-Corps Sites)||In order to contribute to a national innovation ecosystem, NSF established the NSF Innovation Corps Sites Program (NSF I-Corps Sites). Sites are funded at academic institutions, having already existing innovation or entrepreneurial units, to enable them to:
||Second Thursday in February|
|Restricted-Access Research Data Centers (RDCs)||This solicitation invites proposals for the establishment of new Research Data Centers (RDCs). RDCs are secure Census Bureau facilities within which external researchers are given access to confidential micro data in accordance with specific statutory requirements. NSF will provide start-up costs for new RDC facilities. Potential investigators first must contact Census regarding the feasibility of sponsoring an RDC prior to submitting a proposal to NSF.||September 30, annually|
|Type||Sponsor||URL||Description||Deadline||I am interested|
|Multidisciplinary University Research Initiatives (MURI) Program||DOD||Multidisciplinary University Initiative (MURI) efforts involve teams of researchers investigating high priority topics and opportunities that intersect more than one traditional technical discipline. For many military problems this multidisciplinary approach serves to stimulate innovations, accelerate research progress and expedite transition of results into naval applications.||If renewed: whilte paper in August|
|Collaborative Research Grants||NEH||Collaborative Research Grants support interpretive humanities research undertaken by two or more collaborating scholars, for full-time or part-time activities for periods of one to three years. Support is available for various combinations of scholars, consultants, and research assistants; project-related travel; field work; applications of information technology; and technical support and services. All grantees are expected to disseminate the results of their work to the appropriate scholarly and public audiences.
Eligible projects include:
|December 6, 2017|
|Collaborative Activity Awards||James S. McDonnell Foundation||The Foundation offers Collaborative Activity Awards to initiate interdisciplinary discussions on problems or issues, to help launch interdisciplinary research networks, or to fund communities of researchers/practitioners dedicated to developing new methods, tools, and applications of basic research to applied problems.
In each case the focus of the collaborative activity must meet the program guidelines for one of the following program areas:
|Scialog||Research Corporation for Science Advancement||Scialog supports research, intensive dialog and community building to address scientific challenges of global significance. Within each multi-year initiative, Scialog Fellows collaborate in high-risk discovery research on untested ideas and communicate their progress in annual closed conferences. Intensive discussions identify bottlenecks and encourage innovative approaches.
Ultimately Scialog aims to advance human knowledge by empowering a national community of early career scientists with many promising years of research ahead of them. Through the give-and-take of community building, it is the Foundation's hope that Scialog Fellows grow better equipped to tackle ever more challenging multidisciplinary problems. Success for Scialog Fellows is measured by highly impactful results, ongoing support from private foundations and federal agencies, and, ultimately, scientific breakthroughs. The Scialog process is guided by senior scientists recognized as world-leading researchers in the area of focus.
At a glance, Scialog is intended to:
1) support early career faculty to expand research in a focused area of high scientific importance;
2) encourage scientists to form multidisciplinary teams to tackle these critical challenges, and;
3) help transition awardees to obtain further funding for their innovative ideas.
|Team Science Award Program||Melanoma Research Alliance||The Team Science Award Program is the centerpiece of the MRA research funding portfolio. This program fulfills one of MRA's primary goals: to foster a collaborative research process. Multidisciplinary teams consist of Principal Investigators with complementary expertise who may be from the same institution, inter-institutional, and/or international. Team science projects promote transformational melanoma research advances with the potential for rapid clinical translation.|
|Challenge Awards||Prostate Cancer Foundation||One of PCF's goals is to support transformational prostate cancer research to accelerate progress towards the reduction of death and suffering due to recurrent or advanced prostate cancer. How do we hope to accomplish this? By funding cross-disciplinary teams of investigators in strategic areas through our Challenge Awards.
Teams may be assembled from one institution, or from several institutions and should be comprised of at least three highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. Ranging from $300,000 to $1,500,000 per year for 3 years, these awards will cover direct costs of the research.
|Specialized Center of Research Program||Leukemia & Lymphoma Society||The SCOR program intends to bring together distinguished investigators from one or several institutions to develop a focused research Center, foster new interactions and cooperation, and enhance interdisciplinary research among the participants to understand the causes of various hematological malignancies and ultimately develop effective treatments for cancer patients.|
|Research Networks||MacArthur Foundation||The Foundation supports interdisciplinary research networks, "research institutions without walls," on topics related primarily to human and community development. They are Foundation-initiated projects that bring together highly talented individuals from a spectrum of disciplines, perspectives, and research methods. The networks examine problems and address empirical questions that will increase the understanding of fundamental social issues and are likely to yield significant improvements in policy and practice.|